Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8⁺ T cellsPETROVAS, Constantinos; MUELLER, Yvonne M; DIMITRIOU, Loannis D et al.Blood. 2007, Vol 109, Num 6, pp 2505-2513, issn 0006-4971, 9 p.Article

Pharmacokinetics and Pharmacodynamics of Once-Daily versus Twice-Daily Raltegravir in Treatment-Naïve HIV-Infected PatientsRIZK, Matthew L; YAMING HANG; LUO, Wen-Lin et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3101-3106, issn 0066-4804, 6 p.Article

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trialsERON, Joseph J; YOUNG, Benjamin; KUMAR, Princy N et al.Lancet (British edition). 2010, Vol 375, Num 9712, pp 396-407, issn 0140-6736, 12 p.Article

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trialLENNOX, Jeffrey L; DEJESUS, Edwin; BARNARD, Richard J. O et al.Lancet (British edition). 2009, Vol 374, Num 9692, pp 796-806, issn 0140-6736, 11 p.Article

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trialSULKOWSKI, Mark; POL, Stanislas; WENNING, Larissa et al.Lancet. Infectious diseases (print). 2013, Vol 13, Num 7, pp 597-605, issn 1473-3099, 9 p.Article

Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studiesROCKSTROH, Jürgen K; TEPPLER, Hedy; JING ZHAO et al.AIDS (London). 2011, Vol 25, Num 11, pp 1365-1369, issn 0269-9370, 5 p.Article

High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical TrialGANESAN, Anuradha; CRUM-CIANFLONE, Nancy; BAVARO, Mary et al.The Journal of infectious diseases. 2011, Vol 203, Num 6, pp 756-764, issn 0022-1899, 9 p.Article

Long-term Treatment With Raltegravir or Efavirenz Combined With Tenofovir/ Emtricitabine for Treatment-Naive Human Immunodeficiency Virus-1-Infected Patients: 156-Week Results From STARTMRKROCKSTROH, Jiirgen K; LENNOX, Jeffrey L; DINUBILE, Mark J et al.Clinical infectious diseases. 2011, Vol 53, Num 8, pp 807-816, issn 1058-4838, 10 p.Article

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialERON, Joseph; ROCKSTROH, Jürgen K; NELSON, Mark et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 12, pp 907-915, issn 1473-3099, 9 p.Article

CD4⁺ T cell responses to interleukin-2 administration in HIV-infected patients are directly related to the baseline level of immune activationSERETI, Irini; SKLAR, Peter; DAVEY, Richard T et al.The Journal of infectious diseases. 2007, Vol 196, Num 5, pp 677-683, issn 0022-1899, 7 p.Article

Prevalence and clinical correlates of HIV viremia ('blips') in patients with previous suppression below the limits of quantificationSKLAR, Peter A; WARD, Douglas J; BAKER, Rose K et al.AIDS (London). 2002, Vol 16, Num 15, pp 2035-2041, issn 0269-9370, 7 p.Article

Lopinavir-ritonavir : Effects on endothelial cell function in healthy subjectsGRUBB, Jessica R; DEJAM, André; VOELL, Jocelyn et al.The Journal of infectious diseases. 2006, Vol 193, Num 11, pp 1516-1519, issn 0022-1899, 4 p.Article

Five-year follow-up of a cohort of profoundly immunosuppressed patients discontinuing therapy for cytomegalovirus retinitisSKLAR, Peter A; AGYEMANG, Amma F; MONASTRA, Rachelle et al.AIDS (London). 2004, Vol 18, Num 3, pp 567-569, issn 0269-9370, 3 p.Article

Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: Effects on drug toxicity and on immunologic and virologic parametersDYBUL, Mark; NIES-KRASKE, Elizabeth; HIDALGO, Bertha et al.The Journal of infectious diseases. 2003, Vol 188, Num 3, pp 388-396, issn 0022-1899, 9 p.Article